title: The clinical immunobiology of interleukin-2: potential modified uses for improved cancer treatment.
authors.forename: S D
authors.initials: SD
authors.lastname: Voss
authors.forename: G
authors.initials: G
authors.lastname: Weil-Hillman
authors.forename: J A
authors.initials: JA
authors.lastname: Hank
authors.forename: J A
authors.initials: JA
authors.lastname: Sosman
authors.forename: P M
authors.initials: PM
authors.lastname: Sondel
mesh_terms: D000818:Animals; D003602:Cytotoxicity, Immunologic; D004341:Drug Evaluation; D005544:Forecasting; D006649:Histocompatibility Antigens / Q000276:immunology; D006801:Humans; D007167:Immunotherapy; D007376:Interleukin-2 / Q000502:physiology / Q000627:therapeutic use*; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D008213:Lymphocyte Activation; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*
chemical_list: D006649:Histocompatibility Antigens; D007376:Interleukin-2